Mirtazapine (adjunct) versus placebo for schizophrenia

Suzanne Stricklin, Luke A. Perry, Dhruvesh Ramson

Research output: Contribution to journalArticleOtherpeer-review

1 Citation (Scopus)


This is the protocol for a review and there is no abstract. The objectives are as follows: To systematically assess the effects of mirtazapine as adjunct treatment for people with schizophrenia.

Original languageEnglish
Article numberCD011943
Number of pages13
JournalCochrane Database of Systematic Reviews
Issue number11
Publication statusPublished - 11 Nov 2015

Cite this